Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore ...

When Nikki Myers, 33, found a lump in her neck last fall, she visited an urgent care clinic. She learned she had ovarian ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but ...

Researchers identify PPP2R1A gene mutations as a new marker linked to better immunotherapy response and survival in ovarian ...

Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

Former marathon runner Paula Radcliffe revealed she and her husband Gary Lough initially dismissed the early signs of ovarian ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...